O
OS Therapies Inc
AMEX:OSTX
OS Therapies Inc
AMEX:OSTX
Price:
1.483
USD
-1.79%
Market Cap:
$52.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
OS Therapies Inc
AMEX:OSTX
|
US |
|
D
|
Develia SA
WSE:DVL
|
PL |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
MX |
|
A
|
Arabian Drilling Co
SAU:2381
|
SA |
|
Kawata Mfg. Co Ltd
TSE:6292
|
JP |
|
Acreage Holdings Inc
OTC:ACRDF
|
US |
|
Redcentric PLC
LSE:RCN
|
UK |
|
C
|
Construction And Investment JSC No 18
VN:L18
|
VN |
|
Jones Tech PLC
SZSE:300684
|
CN |
Income Statement
Earnings Waterfall
OS Therapies Inc
OS Therapies Inc
Income Statement
OS Therapies Inc
OS Therapies Inc
Currency: USD
| Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
2
|
2
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(5)
|
(7)
|
(11)
|
(15)
|
(20)
|
(29)
|
|
| Selling, General & Administrative |
(2)
|
(4)
|
(7)
|
(9)
|
(11)
|
(12)
|
|
| Research & Development |
(3)
|
(3)
|
(4)
|
(6)
|
(8)
|
(16)
|
|
| Operating Income |
(5)
N/A
|
(7)
-36%
|
(11)
-64%
|
(15)
-36%
|
(20)
-29%
|
(29)
-46%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
0
|
|
| Total Other Income |
0
|
(0)
|
1
|
1
|
0
|
(0)
|
|
| Pre-Tax Income |
(7)
N/A
|
(9)
-21%
|
(11)
-27%
|
(14)
-26%
|
(18)
-28%
|
(29)
-57%
|
|
| Net Income | |||||||
| Income from Continuing Operations |
(7)
|
(9)
|
(11)
|
(14)
|
(18)
|
(29)
|
|
| Net Income (Common) |
(7)
N/A
|
(11)
-47%
|
(13)
-22%
|
(16)
-22%
|
(20)
-25%
|
(29)
-42%
|
|
| EPS (Diluted) |
-0.36
N/A
|
-0.88
-144%
|
-0.62
+30%
|
-0.64
-3%
|
-0.63
+2%
|
-0.98
-56%
|
|
Switch to:
Switch to:
See Also
Discover More
